基本信息:
- 专利标题： SINGLE DOMAIN ANTIBODY FOR CTLA4 AND DERIVED PROTEIN THEREOF
- 申请号：EP17798775.7 申请日：2017-05-19
- 公开(公告)号：EP3459597A1 公开(公告)日：2019-03-27
- 发明人： XU, Ting , WANG, Xiaoxiao , LI, Jie , WU, Haiyan , GAO, Li , CHU, Qian , BAI, Yu
- 申请人： Suzhou Alphamab Co., Ltd , Zhang, Xitian , Zhang, Xin
- 申请人地址： Building C23 BioBay Xinghu Street No. 218 Suzhou Jiangsu 215125 CN
- 专利权人： Suzhou Alphamab Co., Ltd,Zhang, Xitian,Zhang, Xin
- 当前专利权人： Suzhou Alphamab Co., Ltd,Zhang, Xitian,Zhang, Xin
- 当前专利权人地址： Building C23 BioBay Xinghu Street No. 218 Suzhou Jiangsu 215125 CN
- 代理机构： Michalski Hüttermann & Partner Patentanwälte mbB
- 优先权： CN201610332590 20160519
- 国际公布： WO2017198212 20171123
- 主分类号： A61P35/00
- IPC分类号： A61P35/00 ; C07K16/28 ; A61K39/395
摘要：
The present invention relates to the field of medical biology, and discloses a single domain antibody and derivative proteins thereof against CTLA4. In particular, the present invention discloses a CTLA4 binding protein and the use thereof, especially the use for treating and/or preventing CTLA4 relevant diseases such as tumor.
公开/授权文献:
- EP3459597B1 SINGLE DOMAIN ANTIBODY FOR CTLA4 AND DERIVED PROTEIN THEREOF 公开/授权日：2022-08-31
IPC结构图谱:
| A | 人类生活必需 |
| --A61 | 医学或兽医学；卫生学 |
| ----A61P | 化合物或药物制剂的治疗活性 |
| ------A61P35/00 | 抗肿瘤药 |